Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.
2.

Glycopeptide carboxamides active against vancomycin-resistant enterococci.

Zweifel MJ, Snyder NJ, Cooper RD, Nicas TI, Mullen DL, Butler TF, Rodriguez MJ.

J Antibiot (Tokyo). 2003 Mar;56(3):289-95.

3.

Enzymatic deacylation of teicoplanin followed by reductive alkylation: synthesis and antibacterial activity of new glycopeptides.

Snyder NJ, Cooper RD, Briggs BS, Zmijewski M, Mullen DL, Kaiser RE, Nicas TI.

J Antibiot (Tokyo). 1998 Oct;51(10):945-51.

4.

3-trifluoromethylcarbacephems: synthesis of broad spectrum antibacterial compounds.

Cook GK, Hornback WJ, McDonald JH 3rd, Munroe JE, Snyder NJ.

Bioorg Med Chem Lett. 1998 May 19;8(10):1261-6.

PMID:
9871746
5.

Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci.

Rodriguez MJ, Snyder NJ, Zweifel MJ, Wilkie SC, Stack DR, Cooper RD, Nicas TI, Mullen DL, Butler TF, Thompson RC.

J Antibiot (Tokyo). 1998 Jun;51(6):560-9.

6.
7.

Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.

Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Zweifel MJ, Wilkie SC, Rodriguez MJ, Thompson RC, Cooper RD.

Antimicrob Agents Chemother. 1996 Sep;40(9):2194-9.

8.

Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity.

Cooper RD, Snyder NJ, Zweifel MJ, Staszak MA, Wilkie SC, Nicas TI, Mullen DL, Butler TF, Rodriguez MJ, Huff BE, Thompson RC.

J Antibiot (Tokyo). 1996 Jun;49(6):575-81.

9.

Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.

Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Stratford RE, Cooper RD.

Antimicrob Agents Chemother. 1995 Nov;39(11):2585-7. Erratum in: Antimicrob Agents Chemother 1996 May;40(5):1330.

10.

C(3)-cyclopropyl cephems and carbacephems.

Spry DO, Snyder NJ, Kasher JS.

J Antibiot (Tokyo). 1989 Nov;42(11):1653-60.

11.

Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

Lipman LM, Green DE, Snyder NJ, Nelson JC, Solomon DH.

Am J Med. 1967 Oct;43(4):486-98. No abstract available.

PMID:
6072779
12.

GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE.

SNYDER NJ, GREEN DE, SOLOMON DH.

J Clin Endocrinol Metab. 1964 Nov;24:1129-35. No abstract available.

PMID:
14230010

Supplemental Content

Loading ...
Support Center